Abstract
Nuclear magnetic resonance (NMR) methods that quantitatively probe motions on molecular and atomic levels have propelled the understanding of biomolecular processes for which static structures cannot provide a satisfactory description. In this work, we studied the structure and dynamics of the essential 100-kDa eukaryotic 5′→3′ exoribonuclease Xrn2. A combination of complementary fluorine and methyl-TROSY NMR spectroscopy reveals that the apo enzyme is highly dynamic around the catalytic center. These observed dynamics are in agreement with a transition of the enzyme from the ground state into a catalytically competent state. We show that the conformational equilibrium in Xrn2 shifts substantially toward the active state in the presence of substrate and magnesium. Finally, our data reveal that the dynamics in Xrn2 correlate with the RNA degradation rate, as a mutation that attenuates motions also affects catalytic activity. In that light, our results stress the importance of studies that go beyond static structural information.
Subject terms: Enzymes, NMR spectroscopy, X-ray crystallography
Using methyl group and fluorine NMR spectroscopic methods, Overbeck et al revealed that the dynamics of the eukaryotic 5′→3′ exoribonuclease Xrn2 in the region around the active site are correlated with its catalytic activity.
Main
5′→3′ exoribonucleases are essential enzymes that processively remove nucleotides from the 5′ end of RNA1–4. In the nucleus, this process is carried out by the exoribonuclease Xrn2 (Rat1), which is important for the removal of aberrant pre-mRNAs5, rRNA maturation and decay6–9, the processing of small nucleolar RNA (snoRNA)10,11, transcription termination12,13, telomere length regulation14 and the degradation of microRNAs15 and hypomodified transfer RNAs (tRNAs)16. This multitude of cellular functions renders Xrn2 essential in Saccharomyces cerevisiae17,18 and Schizosaccharomyces pombe19,20 and during development in Caenorhabditis elegans21.
The molecular basis of RNA degradation by Xrn2 and its cytoplasmic paralogue Xrn1 has been established by several studies. Both enzymes are highly selective for substrates with exposed 5′-monophosphorylated ends and require divalent cations to catalyze the hydrolysis of phosphodiester bonds22,23. Xrn enzymes are highly processive and remove tens of nucleotides per second from the substrate24–28. The combination of processivity and speed is important, as this enables Xrn1 to closely follow ribosomes in co-translational mRNA decay29–32 and allows Xrn2 to chase RNA polymerase II in co-transcriptional RNA degradation after cleavage of the pre-mRNA at the polyadenylation signal33.
On a structural level, Xrn1 and Xrn2 share two conserved regions (CR1 and CR2) and a less conserved C-terminal segment (CTS), which together form the Xrn core domain25,27,34 (Fig. 1a–c and Supplementary Figs. 1 and 2). This Xrn core harbors the catalytic site, which has three crucial features. First: a set of seven conserved acidic residues that mediate the coordination of two divalent cations, which are important for catalysis and substrate binding25–27,35,36 (Fig. 1d). Second: an adjacent basic binding pocket that is responsible for the selective recognition of the 5′ phosphate of the substrate27. This pocket rationalizes that neither unphosphorylated (no recognition) nor 5′-triphosphorylated or 5′-capped RNAs (steric hindrance) are substrates of Xrn1 or Xrn2. Third: two conserved residues (one histidine and one tryptophan) that sandwich the aromatic rings of the first three substrate nucleotides in an extensive base stack, thereby contributing to the processivity of the enzyme27. This static view of the enzyme:substrate complex has been expanded by the comparison of two Xrn1 structures that display different states during the catalytic cycle (Fig. 1a and Supplementary Fig. 2). First: a crystal structure of the Drosophila melanogaster Xrn1 enzyme in complex with a pseudo-substrate DNA displays the enzyme in a post-translocation, pre-hydrolysis (active) state. This state was stabilized by a mutation that disturbed one of the Mg2+ binding sites as well as by the missing 2′-hydroxyl group in the substrate27. A second snapshot of the catalytic cycle was provided by a cryogenic electron microscopy (cryo-EM) structure of S. cerevisiae Xrn1 that is stably bound to a stalled ribosome and in the presence of an mRNA substrate. In this latter structure, the π–π stack of the first three bases could be observed, but, at the same time, the terminal 5′-phosphate had yet to be fully translocated to the basic pocket30. This state was interpreted as a pre-translocation state. Based on these snapshots, it was noted that substantial conformational changes accompany the substrate translocation step, with a particularly pronounced rearrangement taking place at the N-terminal α1-helix of Xrn1 (ref. 30). This helix is functionally important, and it has been postulated to constitute a steric hindrance for double-stranded RNA27. In addition, deletion of the first four residues results in reduced catalytic activity26. Although no structural data have been reported for Xrn2 in a substrate-bound state, the conservation of CR1 and CR2 between Xrn1 and Xrn2 indicate that both enzymes share a common molecular mechanism, in which the N-terminal α1-helix can adopt two functionally important conformations.
In this work, we studied the interplay of structure and dynamics in the 100-kDa Xrn2 enzyme. To that end, we combined X-ray crystallography with NMR relaxation dispersion measurements on 13CH3-labeled and 19F-labeled Xrn2 samples. We found that the N-terminal region of the apo enzyme transiently populates an excited state that resembles the pre-hydrolysis substrate-bound state. The functional relevance of the observed helix dynamics is emphasized by a mutant enzyme in which motions and catalytic activity of Xrn2 are reduced.
Results
Chaetomium thermophilum Xrn2 is a canonical 5′→3′ exoribonuclease
High-resolution NMR studies that address protein dynamics require isotope-labeled samples that are stable over multiple days at protein concentration in the high μM range. Obtaining such samples is often a bottleneck, especially for large eukaryotic enzymes. Here, we found that the Xrn2 core from the thermophilic yeast Chaetomium thermophilum (CtXrn2, residues 1–875, molecular weight 100 kDa; Fig. 1b and Supplementary Table 1) fulfills those conditions. To lay the structural foundation for our NMR experiments, we first determined the crystal structure of CtXrn2 (Fig. 1c and Supplementary Table 7). In agreement with the high sequence conservation, we found that the CtXrn2 structure closely resembles those of S. pombe25 and C. elegans37. In addition, the CtXrn2 structure is similar to the core structures of the Xrn1 paralogues from D. melanogaster27, Kluyveromyces lactis26 and S. cerevisiae30 (Supplementary Fig. 3).
The active site of the enzyme is positioned in a pocket in front of the ‘tower’ domain helix (helix α4) (Fig. 1c). Seven acidic residues provide a coordination platform for the two catalytically important Mg2+ ions (Fig. 1d). Furthermore, we found that His61 and Trp706 are correctly positioned above the active site to form a continuous π–π stack with the RNA substrate, as has been observed for Xrn1 in complex with a pseudo-substrate DNA27 and an mRNA substrate in the context of a stalled ribosome30 (Supplementary Fig. 4).
C. thermophilum Xrn2 contains a functional zinc finger
In our structure of the Xrn2 enzyme, electron density is lacking for three regions: (1) the top of the tower domain (residues 135–158) that is also less well defined in other Xrn2 structures; (2) the linker region between CR1 and CR2 (residues 423–568) that is highly flexible in solution (Extended Data Fig. 1); and (3) a short loop between residues 266 and 304 that harbors a putative CCHC zinc finger (ZnF) motif. Such a CX2CX4HX4C ZnF motif (where C, H and X correspond to a cysteine, a histidine and any amino acid, respectively) is present in Xrn2 homologues from higher eukaryotes (Fig. 1e), including C. elegans, where it was deleted from the crystallization construct37, and in a limited number of yeast species (for example, Neurospora crassa and Aspergillus fumigatus). However, the ZnF is missing in Xrn2 homologues from other Ascomycota (inluding S. pombe25 and S. cerevisiae) and is also generally absent in Xrn1. To obtain insights into the functional importance of the Xrn2 ZnF, we solved the NMR structure of this region (Fig. 1f). The structural ensemble (Supplementary Fig. 5 and Supplementary Table 8) displays a well-defined core (residues 269–284) that is similar to ZnFs that interact with (deoxy-)ribonucleotides (Supplementary Fig. 6). In the context of the full-length protein, the ZnF is localized on the side of the enzyme that also contains the active site (Fig. 1c and Extended Data Fig. 2), which prompted us to determine if the Xrn2 ZnF is important for substrate recruitment and/or turnover. To test this, we first measured the binding affinity of 5-mer and 10-mer RNAs to Xrn2. These experiments were recorded in the absence of Mg2+ to prevent the rapid degradation of the RNA substrate, and we found that the substrates bind with low nanomolar affinities (Fig. 1g). We next ‘inactivated’ the ZnF by using an Xrn2 ΔZnF construct. This increased the dissociation constant (reduced the affinity) by a factor of 1.5 (5-mer) to 3 (10-mer), corresponding to a ∆G < 2.7 kilojoules per mole (kJ/mol) at room temperature (Fig. 1g). Second, we investigated if the ZnF plays a role in Xrn2 activity (Supplementary Fig. 7). To that end, we compared the degradation rates of the Xrn2 wild-type (WT) protein with a version of the enzyme that lacks the ZnF. As the importance of the ZnF might depend on the extent of secondary structure in the substrate, we performed degradation assays using five RNA substrates with different stem–loop stabilities (Fig. 1h). We found that RNAs with a stem–loop of low stability were degraded with similar rates in the presence or absence of the ZnF. For RNAs that contain increasingly stable (GC) stem–loop elements, the deletion of the ZnF decreased the relative degradation rate accordingly. Based on the above, we conclude that the ZnF in Xrn2 plays a functionally important role in RNA binding and that it promotes the degradation of structured RNA substrates.
Free Xrn2 displays dynamics in solution
Static structures from the Xrn2 paralogue Xrn1 indicate that the N-terminal α1-helix adopts different conformations in the apo and substrate-bound states and that the associated motions are correlated with translocation of the RNA substrate toward the active site (Fig. 1a and Supplementary Fig. 2)27,30. The sequence and structure of the α1-helices from Xrn2 and Xrn1 are conserved (Supplementary Fig. 8), although it should be noted that the electron density for the first residues is less well defined in the Xrn1 and Xrn2 crystal structures in the apo state25,26,37. Although there are no direct structural data for substrate-bound Xrn2, we reasoned that Xrn2 and Xrn1 undergo similar conformational changes during the catalytic cycle. In this process, the N-terminal α1-helix has been suggested to function as a Brownian ratchet that supports the translocation of the substrate RNA (Fig. 1a and Supplementary Fig. 2)27.
To elucidate these and other structural dynamics in Xrn2, we turned to a methyl-TROSY (transverse relaxation-optimized spectroscopy) NMR approach. Heteronuclear multiple quantum coherence (HMQC) spectra of Ileδ1-[13CH3]-labeled and Metε-[13CH3]-labeled Xrn2 samples are of very high quality, especially when considering that Xrn2 is a 100-kDa single-chain protein (Fig. 2a). To be able to reveal site-specific information, we assigned M704 as well as 38 of the 48 isoleucine resonances (Supplementary Table 2). A subset of these isoleucine probes showed substantial peak broadening at 313 K and could only be assigned at 293 K (Fig. 2b and Extended Data Fig. 3). Importantly, we noted that the resonances that broaden at higher temperature cluster around the α1-helix, which indicates that this region of the enzyme undergoes a conformational exchange process on the microsecond to millisecond time scale. To verify this hypothesis, we recorded methyl group single-quantum (SQ) and multiple-quantum (MQ) Carr–Purcell–Meiboom–Gill (CPMG) relaxation dispersion (RD) experiments at proton Larmor frequencies of 500 MHz, 600 MHz and 800 MHz (Supplementary Fig. 9). These experiments can be used to quantify motions for which the lifetime of the excited state is on the order of milliseconds. We found strong relaxation dispersions in several resonances that surround the α1-helix and could fit all six datasets from five probes simultaneously with the same exchange parameters pES = 18.1 ± 6.2% and kex = 710 ± 63 s−1 (where pES is the population of the excited state, and kex is the exchange rate) (Fig. 2c, Supplementary Table 6 and Extended Data Fig. 4). The precision of the extracted population is limited, as can be judged from the shallow minimum in the reduced χ2 surface (Extended Data Fig. 4). Taken together, our data establish that the α1-‘ratchet’-helix of Xrn2 samples multiple states in solution in the absence of a substrate, whereas other parts of the enzyme are largely devoid of motions on the millisecond time scale (Supplementary Fig. 10)
19F NMR provides an independent measure of α1-helix dynamics
The methyl CPMG RD experiments provided accurate information with a high spatial resolution. However, one drawback of those experiments is the extended measurement time that is required (>2 days per dataset). This prevents the execution of NMR measurements in the presence of substrates, as these would be turned over before the acquisition of the data is finished. Recently, we showed that 19F RD data can be recorded in substantially less time and that this approach can provide accurate insights into bio-molecular exchange processes38. Here, we introduced a cysteine in Xrn2 at position 12 that is located at the end of the α1-helix and exposed on the surface (Fig. 3a,b), and we labeled this residue with bromotrifluoroacetone (BTFA) (Supplementary Fig. 11).
Based on time-efficient one-dimensional (1D) 19F NMR spectra (Fig. 3c), we recorded CPMG and on-resonance R1ρ relaxation dispersion data at 1H Larmor frequencies of 500 MHz and 600 MHz and at five temperatures between 303 K and 313 K (Fig. 3d,e and Extended Data Fig. 5). For all temperatures, we observed strongly enhanced effective transverse relaxation rates at CPMG/spin-lock frequencies below 500 Hz. We fit all data simultaneously with a single global chemical shift difference parameter | Δω | and temperature-dependent parameters for excited state populations pEStemp and exchange rates kextemp (Supplementary Figs. 12 and 13). We obtained | Δω | = 0.15 ± 0.01 p.p.m. and found that kex increased from 445 ± 67 s−1 to 913 ± 108 s−1 between 303 K and 313 K (Fig. 3e and Extended Data Fig. 6). The population of the excited state is high (> ~20%) for all temperatures, although it is not possible to determine pES with high accuracy, as was the case for the 13C data. We note that the CPMG data contain less information than the on-resonance R1ρ data, as, for the latter, it is possible to record more data points at low (spin-lock) frequencies that are most sensitive to the exchange parameters (Supplementary Fig. 12 and Supplementary Table 6). The finding that the motions in Xrn2 are localized to a region around the active site is corroborated by measurements on samples where the 19F label has been positioned at other sites in Xrn2 (Supplementary Fig. 14). In addition, we found that 19F RD profiles that we recorded for a specific position are the same for enzymes that have been labeled using BTFA or trifluoroethanethiol (TET) (Fig. 3f). Together, these observations establish that our 19F RD profiles are suitable for detecting dynamic processes of the region around the active site of Xrn2. The exchange rates at 313 K (kex) that we extract from the 19F data and from the methyl-TROSY data at 313 K are compatible (kexCH3 = 710 ± 63 s−1 and kex19F = 913 ± 108 s−1), whereas pES is, in both cases, relatively high. The consistency of the 13C and 19F measurements is further confirmed by a global fit of the 13C and 19F RD data (Extended Data Fig. 7), from which we obtained an exchange rate of 864 ± 112 s−1 (Supplementary Table 6).
Substrate binding changes the structure and dynamics of Xrn2
The fast degradation of RNA by Xrn2 prevents the NMR characterization of a complex between Xrn2 and an RNA substrate. To investigate the structural changes that occur in Xrn2 upon substrate interaction, we used three substrates with strongly attenuated degradation rates: 3′,5′-bisphosphoadenosine (pAp), a 5-mer DNA and an exoribonuclease-resistant RNA (xrRNA)39. It is important to note that we use the catalytically active WT Xrn2, as versions of the enzyme that lack the catalytically important magnesium ions likely display altered interactions and/ or motions.
First, we used pAp40, which is hydrolyzed to adenosine 5′-monophosphate (AMP) at a rate of 0.05 min−1 (Fig. 4a). This allowed us the measurement of HMQC spectra of Ileδ1-[13CH3]-labeled Xrn2 in the presence of an excess of pAp (Fig. 4b). The binding of pAp to Xrn2 resulted in substantial chemical shift perturbations (CSPs) of the methyl group resonances that are in agreement with a conformational change around the active site of the enzyme (Fig. 4c). Interestingly, the carbon chemical shifts of the excited apo state that we extract from the CPMG experiments (Fig. 2c) correlate linearly with the carbon chemical shifts that we measure in the presence of pAp (Fig. 4d). Likewise, the 19F chemical shift difference upon the addition of pAp to Xrn2-deltaZnF-N12CBTFA (0.10 p.p.m.) is in agreement with pGS ∙ |Δω | (= 0.07–0.12 p.p.m. for 0.5 < pGS < 0.8 and | Δω | = 0.149 p.p.m.) that we determined from the RD experiments in the absence of the substrate (Fig. 4e). These findings support the notion that the apo enzyme transiently populates a state that is structurally similar to the pAp-bound conformation. Interestingly, 19F line widths and RD experiments reveal that the dynamics in Xrn2 are substantially reduced upon substrate binding (Fig. 4f). Taken together, our data reveal that Xrn2 locks into a stable active conformation (the post-translocation state) upon substrate recruitment. As a consequence of the more rigid nature of the Xrn2:substrate complex, we were able to assign nine additional Xrn2 methyl resonances (Fig. 4c) that were broadened beyond detection in the apo state due to conformational exchange.
To obtain additional information on the structural and conformational changes in Xrn2 upon substrate binding, we next made use of a 5′-phosphorylated DNA pentanucleotide (pdA5) that is readily degraded into a 2-mer DNA (pdA2) and free nucleotides (Supplementary Fig. 15). pdA2 is one nucleotide longer than the pAp that we used above (Fig. 4b) yet induced similar chemical shift perturbations in the HMQC spectrum (Fig. 4g and Supplementary Fig. 16). In analogy to pAp binding, the binding of pdA2 to Xrn2 also abolished the extensive motions in the enzyme (Fig. 4h). pAp and pdA2, thus, both induce the post-translocation conformation in Xrn2. Interestingly, in the presence of pdA2, we noticed a CSP of Met704 that was absent in the pAp-bound states (Fig. 4g). As pdA2 is one base longer than pAp, we concluded that the CSP of Met704 reports on the location of the second base of the Xrn2 substrate. In the structure of Xrn2, Met704 is positioned in direct proximity to the conserved Trp706 residue, which stacks with the third nucleotide base in the structure of Xrn1 bound to a 5′-phosphorylated DNA 11-mer27,30. Based on that, Met704 is, thus, an excellent probe that reports on the occupancy of the RNA-binding pocket next to the active site.
In the absence of Mg2+, pdA5 is not degraded to pdA2 by Xrn2 (Supplementary Fig. 15). Under these conditions, pdA5 is recruited to the RNA-binding pocket (as reported by Met704; Extended Data Fig. 8), but the active post-translocation conformation in Xrn2 (as reported by the methyl-TROSY spectra; Extended Data Fig. 8) is not stably formed. This is also confirmed by 19F RD measurements that show that the binding of pdA5 to Xrn2 in the absence of magnesium has no effect on the dynamics of the N-terminal α1-helix. From that, we conclude that the divalent ions in the active site play an important role in the transition of Xrn2 from the pre-translocation state to the post-translocation state. This finding underscores the importance of performing experiments on the holoenzyme as the Mg2+ ions are required for both catalysis and the stable formation of the active post-translocation conformation.
Finally, we used a modified xrRNA derived from a subgenomic flavivirus RNA from Zika virus as an Xrn2 substrate. This RNA contains an unstructured 5′ end followed by a highly stable pseudoknot that is resistant to the 5′→3′ exoribonuclease activity of Xrn1 (ref. 39). The addition of Xrn2 to this xrRNA results in the rapid hydrolysis of the unstructured 5′ region and the subsequent formation of a stable complex between Xrn2 and the xrRNA pseudoknot that is sterically hindered to translocate into the active state. (Supplementary Fig. 17). The HMQC spectrum of this complex shows overall reduced peak intensities that are particularly pronounced for resonances of residues between the α3-helix and the active site (Fig. 4I and Supplementary Fig. 18). The reduced resonance intensities can be attributed to the increase in molecular weight and the large number of protons from the xrRNA that come close to Xrn2 methyl groups and, thereby, enhance relaxation rates. Nevertheless, we can conclude that the active post-translocation state of the enzyme is not stably formed, as the signature chemical shifts of the active state (Fig. 4b) are not fully observed. Met704, on the other hand, shows a clear CSP, which confirms that the 5′ end of the trimmed xrRNA interacts in the substrate-binding pocket. Taken together, these data show that the Xrn2 enzyme is locked in a pre-translocation state in the presence of the xrRNA product, as was observed in the cryo-EM structure of Xrn1 in the presence of a stalled ribosome30.
In summary, our data reveal that the apo Xrn2 enzyme is in a dynamic equilibrium between the pre-translocation and post-translocation states. Upon recruitment of a substrate and in the presence of Mg2+, Xrn2 mainly adopts the post-translocation state.
The A5F mutation alters Xrn2 dynamics and activity
To investigate how the dynamics in Xrn2 are correlated with RNA substrate degradation, we introduced single point mutations in or close to the α1-helix with the aim of changing the dynamics around the active site (Supplementary Table 5). We found that the A5F mutation led to substantially reduced relaxation dispersions (Fig. 5a), indicative of substantial changes in the energy landscape of the enzyme. It is important to note that this mutation does not interfere with the overall structure of the enzyme or with the interaction between the substrate and the enzyme (Extended Data Fig. 9). These data can be explained by a higher energy barrier between the pre-translocation and post-translocation states. Interestingly, we found that the A5F mutation decreases the activity of Xrn2 by 30–50%, depending on the substrate (Fig. 5b). Based on these findings, we conclude that the A5F mutation results in changes in the dynamics of Xrn2 and, at the same time, in a decrease in the enzymatic turnover rates.
Regulation of Xrn2 activity
In previous studies, it was shown that the activity of Xrn2 can be enhanced by the interaction with binding partners25,41. On the one hand, Xrn2 in higher eukaryotes can recruit XRN2-binding domain (XTBD) containing binding partners that have been proposed to stabilize the Xrn2 fold in the absence of a substrate37. However, in our crystal structure of apo CtXrn2, this XTBD segment is already fully folded (Supplementary Fig. 19), and the chemical shifts of Ile687 and Ile688 δ1-methyl groups clearly deviate from the shift of Ileδ1-methyl groups in unstructured regions (Fig. 2a). As XTBD-containing proteins have only been identified in metazoa37,41, our findings suggest that the mechanisms that regulate the catalytic activity of Xrn2 differ between yeast and metazoa. On the other hand, yeast Xrn2 directly interacts with the pyrophosphohydrolase Rai1 in S. pombe; this interaction enhances the activity of the enzyme due to the Rai1-induced stabilization of the Xrn2 fold25. Xrn2 and Rai1 also form a stable complex in C. thermophilum (Supplementary Fig. 20); however, we observe that the recruitment of CtRai1 to CtXrn2 does not result in an enhancement of Xrn2 activity (Supplementary Fig. 21), and neither are the structure or motions in the active site of Xrn2 influenced by Rai1 binding (Extended Data Fig. 10). In S. pombe, Rai1 enhances Xrn2 activity especially for RNA substrates that contain stable secondary structure elements, indicating that Rai1 possesses RNA unwinding activity. In C. thermophilum, this unwinding activity appears to have moved from the Xrn2-interacting protein Rai1 to the ZnF in the enzyme.
Discussion
Static macromolecular structures provide important information about biochemical mechanisms. It is, however, important to realize that these static structures (1) do not necessarily represent the ground state conformation of the macromolecule in solution42 and (2) fail to reveal the dynamical processes that underlie allostery43,44 or catalysis45–47. In that regard, it is, thus, of central importance to complement our understanding of molecular function with information regarding dynamic processes, although this can be technically highly challenging48.
A catalytic cycle of a chemical reaction comprises multiple steps, where the overall rate of the reaction is limited by the slowest of these steps. Enzymes can increase the speed of these reactions substantially, by reducing the rate-limiting step that typically involves the breaking or formation of chemical bonds. In an enzyme-catalyzed chemical reaction, the slowest step can then change from the chemical step to a conformational change in the enzyme. This has been shown to be the case for, for example, dihydrofolate reductase (DHFR), which needs to rearrange from a closed conformation where catalysis can take place to an occluded conformation that is required for product release49. Likewise, the opening of a lid domain was found to constitute the rate-limiting step in the reaction cycle of hyperthermophilic and mesophilic homologs of the enzyme adenylate kinase50.
In this study, we exploited methyl-TROSY (Figs. 2 and 4) and 19F (Figs. 3, 4 and 5) NMR techniques, and we show that the N-terminal α1-helix in the 5′→3′ exoribonuclease Xrn2 is highly dynamic. In the apo state, the enzyme adopts the pre-translocation (ground) state (Fig. 1a and Supplementary Fig. 2) between 50% and 80% and the post-translocation (active/excited) state between 20% and 50% (kex = 864 s−1; 173 s−1 < kGS-ES < 432 s−1 and 432 < kES-GS < 691 s−1).
Substrate binding shifts the conformational equilibrium to the post-translocation state, likely by reducing the free energy of this conformation. As a result, the backward rate (kES-GS) will be substantially reduced (to less than 10 s−1) while the forward rate (kGS-ES) rate remains unchanged. This scenario is in full agreement with the changes in the 19F RD profile that we observe upon substrate binding (Fig. 4f,h). Interestingly, for RNA substrates without strong secondary structure elements (AU hairpin RNA), the turnover rate (127–163 s−1) is close to the rate with which the enzyme transitions from the pre-translocation state to the post-translocation state (kGS-ES). This suggests that this transition can constitute the rate-limiting step in the catalytic cycle. This notion is further corroborated by the observation that kcat and kex both linearly change with temperature (Extended Data Fig. 6). Finally, the central importance of the dynamics of the N-terminal helix is revealed by the A5F mutant enzyme that results in changes in the energy landscape of Xrn2 (Fig. 5) that coincide with a reduction in the turnover rates.
In summary, we made extensive use of NMR methods to quantify and localize structural changes in Xrn2. It should be noted that Xrn2 (875 residues, 100 kDa) is among the largest single-chain enzymes that have so far been studied using solution-state NMR methods. We exploited methyl labeling strategies, which provide a higher spatial resolution, and 19F labeling, which is able to provide information regarding protein motions in short times. It is important to note that positioning of the fluorine label was directly guided by data obtained from the methyl-labeled samples. We found that an approach that combines methyl group and fluorine labeling is highly efficient. However, we would also like to stress the importance of cross-checking that the methyl and fluorine labels report on the same molecular process. Here, we ensured this by comparing the exchange parameters that were extracted from 13CH3-based and 19F-based RD measurements and by labeling the enzyme with two independent fluorine-containing compounds (BTFA and TET). Importantly, the rapid (1-hour) 19F experiments allowed us to obtain information on catalytically active Xrn2 in the presence of substrates, before those were fully processed. We anticipate that the combination of complementary NMR labeling techniques together with information on static structures will be an important approach to obtain fundamental insights into biologically important dynamics in large enzymes.
Methods
Molecular biology
The protein-coding sequence of Xrn2 from C. thermophilum (National Center of Biotechnology Information (NCBI) reference sequence XP_006691410.1) was synthesized by GenScript with codon optimization for expression in Escherichia coli and provided in a pUC57 vector. A construct encompassing amino acids 1–875 (Supplementary Table 1) was cloned into a pET26b+ vector (Novagen) using NdeI and XhoI restriction sites (hereafter referred to as CtXrn2). The vector carries no additional amino acids at the N-terminus of the construct and a C-terminal His6-tag constituted by the sequence LEHHHHHH, where the amino acids LE are a remnant from the restriction site.
A construct lacking the residues 263–300, corresponding to the ZnF loop (hereafter referred to as CtXrn2 ΔZnF) was prepared using Gibson assembly cloning. All point mutations were introduced using site-directed mutagenesis with a pair of primers designed with PrimerX (http://www.bioinformatics.org/primerx), where the mutated sequence was typically introduced in the middle of the primers. A construct containing the ZnF (residues 265–293) was cloned using Gibson assembly into a pETGB1a vector that carried an N-terminal His6-GB1 tag, followed by a tobacco etch virus (TEV) protease cleavage site. All used constructs were validated by sequencing the full open reading frame.
Protein expression and purification
Plasmids were transformed into E. coli BL21(DE3) CodonPlus-RIL cells (StrataGene) and grown in LB overnight at 37 °C. For unlabeled (non-isotope-labeled) samples, typically 1 L of LB was inoculated from an overnight culture and grown to an OD600 of 0.6–0.8 at 37 °C, at which point the culture was cooled to 20 °C, and protein expression was induced by the addition of 0.5 mM IPTG. For samples with Ile-δ1 13C1H3 methyl group labeling, an H2O-M9 culture was inoculated from the overnight LB culture and grown to OD ~0.2–1.0. Cells of this culture were harvested typically in the afternoon by moderate centrifugation at ~3,000 relative centrifugal force (r.c.f.) and resuspended in D2O-M9 (containing 2 g L−1 of 2H12C-labeled glucose) culture to an OD of 0.1–0.15 with a volume of 1/10 of the final D2O culture volume. The D2O-M9 culture was grown overnight at 37 °C, diluted 1:8 and grown to an OD of 0.6–0.8. A solution of the isoleucine precursor alpha-ketobutyrate in a buffered D2O solution was added to the culture; the temperature was shifted to 20 °C; and protein expression was induced 1 hour later by the addition of 0.5 mM IPTG. Cells were harvested by centrifugation 14–18 hours after induction, and cell pellets were stored at −20 °C. Protein purification followed a two-step protocol with a Ni-affinity chromatography and a gel filtration. In brief, cell pellets were resuspended in 50 mM Na phosphate buffer (pH 7.4), 400 mM NaCl, 10 mM imidazole, 0.1% Triton X-100, 1 mg L−1 of lysozyme and 0.2 U ml−1 of DNase I with vortexing for 30 minutes at 4 °C and lysed by sonication. The cell debris was removed by a centrifugation step at 18,000 r.c.f., and the supernatant was cleared with a 0.45-μm syringe filter and loaded on a gravity flow Ni-NTA column with a typical volume of 2 ml of beads, which was pre-equilibrated with buffer A (50 mM Na phosphate (pH 7.4), 400 mM NaCl and 10 mM imidazole). The column was subsequently washed with at least 10 column volumes of buffer A, and the bound protein was eluted with typically 10–15 ml of buffer B (50 mM Na phosphate (pH 7.4), 150 mM NaCl and 300 mM imidazole), until a Bradford test did not show staining any more, and 1 mM DTT was added to the elution. The elution was concentrated to a volume of 1–1.5 ml and purified by size-exclusion chromatography using a 16/600 Superdex S200 column in GF buffer (25 mM HEPES (pH 7.3), 125 mM NaCl and 1 mM DTT). The target fractions were combined and concentrated. For deuterated samples, the buffer was exchanged in this concentration step by multiple rounds of addition of D2O-GF buffer (25 mM HEPES (pH 7.3), 125 mM NaCl and 1 mM DTT in D2O) and subsequent concentration. NMR samples were supplemented with 0.03% NaN3 and 5% D2O (for samples not in 100% D2O).
The 13C/15N-labeled ZnF was expressed in M9 medium containing 0.5 g L−1 of 15NH4Cl and 2 g L−1 of 1H13C-labeled glucose. The purification followed the procedure described above but included a dialysis step against 50 mM Na phosphate (pH 7.4), 150 mM NaCl and 1 mM DTT with simultaneous TEV protease cleavage after the Ni-affinity chromatography step. The cleaved His6-GB1 tag was removed by applying the solution to a second Ni-affinity chromatography step, where the resin was equilibrated in buffer A. The flow-through of the column was collected, concentrated and purified using a 16/600 Superdex S75 column equilibrated in GF buffer. Target fractions were pooled and concentrated again, and the sample was supplemented with 0.03% NaN3 and 5% D2O.
Crystal structure determination
Crystallization of C. thermophilum Xrn2 1-875 was carried out with vapor diffusion in sitting drops, derived from 0.3 μl of Xrn2 (36 mg ml−1) in 25 mM HEPES (pH 7.3), 125 mM NaCl, 0.5 mM DTT and 0.3 μl of the precipitant reservoir solution (20% w/v PEG3350 and 200 mM magnesium formate). Crystals grew as thin needles within 2–4 weeks. Crystals were shortly incubated in the reservoir solution with 30% glycerol added for cryoprotection before harvesting. Diffraction data were collected at 100 K on the PXII beamline at the Swiss Light Source with a wavelength of 1 Å and processed with XDS51. S. pombe Xrn2 (Rat1, Protein Data Bank (PDB) entry 3FQD) was pruned with the CCP4 utility Chainsaw to serve as a search model for molecular replacement, which was performed with the CCP4 utility Phaser52. The final structure was obtained after performing several cycles of iterative model building and refinement with Coot53 and Phenix54, respectively. Structure factors and coordinates have been deposited in the PDB under accession code 7OPK.
Cysteine fluorine labeling
Proteins were fluorine labeled after gel filtration at protein concentrations of typically 100 μM. For labeling with 3-bromo-1,1,1-trifluoroacetone (BTFA), the sample was cooled on ice, and BTFA was added to a final concentration of 10 mM. The reaction was incubated for 30 minutes on ice and quenched with 20 mM DTT, and the sample was purified over a PD10 or PD Minitrap G-25 desalting column pre-equilibrated with GF buffer. NMR samples were supplemented with 0.03% NaN3 and 5% D2O. For labeling with TET, the sample was cooled to 4 °C; dichloro-(1,10-phenanthroline)-copper (II) (CuPh) was added to a final concentration of 20 μM; and TET was added to a final concentration of 500 μM. The reaction was followed in 19F spectra until free TET was depleted.
RNA preparation
5′-monophosphorylated RNAs were prepared by in vitro transcription (IVT) in the presence of an excess of GMP over GTP. In brief, a template DNA oligonucleotide with the desired RNA sequence in reverse complement followed by a reverse complementary T7 promoter sequence at the 3′ end (5′-TATAGTGAGTCGTATTACG-3′; Supplementary Table 4) was used in equimolar amounts with an antisense T7 promoter oligonucleotide (5′-CGTAATACGACTCACTATAGG-3′) in the reaction at a concentration of 1 μM. The reaction included 40 mM Tris (pH 8.0), 5 mM DTT, 1 mM spermidine, 0.01% Triton X-100, 10–40 mM MgCl2 and 0.2 μM T7 RNA polymerase (prepared in-house). GMP was included at a concentration of 10 mM, and the required nucleoside triphosphates were included typically at 4 mM concentrations, with the exception of GTP, which was used at a concentration of 0.8 mM. IVTs were carried out at 37 °C for 4 hours to overnight, after which 50 mM EDTA was added to dissolve the magnesium-pyrophosphate precipitate. Reaction products were precipitated with 0.7 reaction volumes of isopropanol and 0.1 reaction volumes of 3 M NaOAc (pH 5.3) with subsequent cooling at −20 °C for at least 30 minutes. The precipitate was pelleted by centrifugation, washed with cold 70% ethanol, air dried and resuspended in 5 M urea and 20 mM Tris (pH 8.0). The solution was applied to a preparative anion exchange DNAPac column (Dionex) and separated by size with an NaCl gradient. Fractions containing RNA were analyzed with urea polyacrylamide gel electrophoresis, and the fractions of interest were pooled, precipitated with isopropanol, washed with 70% ethanol and resuspended in H2O. If necessary, the solutions were concentrated with a SpeedVac vacuum concentrator. RNA samples were stored at −20 °C.
For fluorescence anisotropy measurements, RNAs (5-mer 5′-GGAGU-3′ and 10-mer 5′-GGAGGAGAGU-3′) were fluorescently labeled with 6-iodacetamido-fluorescein. To this end, IVTs were carried out in the presence of 200 μM 4-thiouridine, and the RNA was precipitated, washed with 70% ethanol, resuspended in 0.1 M sodium phosphate (pH 8.0) and incubated with 10 mM iodoacetamido-fluorescein at room temperature overnight. The RNA was twice precipitated and resuspended in H2O and purified with a PD MiniTrap column pre-equilibrated with 20 mM Tris (pH 8.0). The RNAs were cleaved after the labeled thiouridine residue with RNase A at 37 °C for 30 minutes and purified by urea polyacrylamide gel electrophoresis.
Activity assays
RNase assays were performed in GF buffer (25 mM HEPES (pH 7.3), 125 mM NaCl and 1 mM DTT) with RNA concentrations of 10–20 μM and protein concentrations of 5–125 nM. Protein samples used for activity assays were prepared freshly and mixed with 0.01% Triton X-100. Next, 10-μl samples were stopped with 30 μl of 8 M urea, after which the samples were immediately heated to 90 °C for 2 minutes and stored at −20 °C for high-performance liquid chromatography (HPLC) analysis. HPLC assays were performed at 40 °C on a DNAPac PA100 column (Dionex) using an HPLC system with automatic injection of 18-μl samples. Substrate and products were separated using a linear NaCl gradient from 5 M urea, 20 mM Tris/HCl (pH 8.0) and 100 mM NaCl to 5 M urea, 20 mM Tris/HCl (pH 8.0) and 600 mM NaCl. For qualitative assays, reactions were stopped using an equivalent volume of 2× RNA loading buffer (8 M urea, 20 mM EDTA (pH 8.0), 2 mM Tris (pH 8.0), 0.025% w/v bromophenol blue and 0.025% w/v xylene cyanole) and analyzed by urea polyacrylamide gel electrophoresis. Activity assays were performed 2–4 times with fully independently purified enzymes. The indicated error bars are the standard deviations that are based on the independent measurements. The raw data can be found in the online Source Data file.
NMR spectroscopy
HMQC SOFAST spectra were recorded with a Bruker Avance III 800-MHz spectrometer equipped with a helium-cooled TCI probehead, unless indicated otherwise. SQ-CPMG and MQ-CPMG55 experiments were recorded with Bruker Avance NEO 500-MHz, 600-MHz and 800-MHz spectrometers equipped with helium-cooled (800 MHz) or nitrogen-cooled (500 MHz and 600 MHz) TCI probeheads as pseudo-3D experiments, where the CPMG frequency was used as a third dimension that was recorded in an interleaved manner. Data were recorded with a recycle delay of 1.5 seconds and carbon acquisition times of 24.8 ms (800 MHz), 29.0 ms (600 MHz) and 29.8 ms (500 MHz). In all CPMG experiments, the constant time TCPMG was set to 24 ms, and frequencies were sampled at 83.3 Hz, 166.7 Hz, 250 Hz, 333.3 Hz, 416.7 Hz, 500 Hz, 666.7 Hz, 833.3 Hz, 1,000 Hz, 1,166.7 Hz, 1,333.3 Hz, 1,666.7 Hz and 2,000 Hz. All datasets were recorded either two or three times to obtain error estimates for all data points. 1H-15N TROSY spectra of Xrn2 and Xrn2 linker (residues 265–293) were recorded with a Bruker Avance III 600-MHz spectrometer equipped with a TXI room temperature probehead.
19F spectra were recorded with Bruker Avance III 500-MHz and 600-MHz spectrometers equipped with nitrogen-cooled TCI probeheads. 1D spectra were recorded with the aring pulse sequence from Bruker. 19F-CPMG and 19F-R1ρ experiments were recorded in a pseudo-2D and pseudo-3D fashion, respectively, using previously published pulse sequences that include an aring sequence38. Data were recorded with a recycle delay of 1.0 second. All 19F-CPMG experiments were recorded with a constant time TCPMG of 16 ms and CPMG frequencies of 62.6 Hz, 125 Hz, 187.5 Hz, 250 Hz, 312.5 Hz, 375 Hz, 437.5 Hz, 500 Hz, 562.5 Hz, 1,000 Hz, 1,500 Hz, 2,500 Hz and 5,000 Hz (experiments on the 500-MHz spectrometer) and CPMG frequencies of 62.5 Hz, 125 Hz, 187.5 Hz, 250 Hz, 312.5 Hz, 375 Hz, 437.5 Hz, 500 Hz, 625 Hz, 1,000 Hz, 1,500 Hz, 2,000 Hz, 2,500 Hz, 3,000 Hz, 3,500 Hz, 4,000 Hz, 4,500 Hz and 5,000 Hz (experiments on the 600-MHz spectrometer), respectively. 19F-R1ρ experiments were recorded with five different spin-lock times TSL (0, 4, 8, 16 and 32 ms) and 18 different spin-lock fields on the 500-MHz spectrometer (50 Hz, 75 Hz, 100 Hz, 125 Hz, 150 Hz, 200 Hz, 250 Hz, 300 Hz, 400 Hz, 500 Hz, 600 Hz, 700 Hz, 800 Hz, 1,000 Hz, 2,500 Hz, 3,000 Hz, 5,000 Hz and 8,000 Hz) as well as 18 different spin-lock fields on the 600-MHz spectrometer (50 Hz, 75 Hz, 100 Hz, 125 Hz, 150 Hz, 200 Hz, 250 Hz, 300 Hz, 400 Hz, 500 Hz, 600 Hz, 800 Hz, 1,000 Hz, 1,500 Hz, 2,000 Hz, 3,000 Hz, 5,000 Hz and 8,000 Hz). The 19F frequency carrier was centered on the respective peak maximum in the 1D 19F spectrum. All 19F relaxation dispersion datasets were recorded in triplicate to obtain experimental errors for all data points, with the exception of V416C (Supplementary Fig. 14), where the errors in the intensities were determined based on the noise level of the spectra. NMR spectra were processed with the NMRPipe/NMRDraw software suite56.
NMR structure calculations of the ZnF
All spectra used for the structure calculation were acquired at 288 K on Bruker Avance III 500-MHz and 600-MHz spectrometers equipped with nitrogen-cooled TCI probeheads. Assignment of the ZnF (residues 265–293) backbone and sidechain resonances was obtained based on the following spectra: 1H15N-HSQC, 1H13C-HSQC, 3D-HNCACB, 3D-HN(CA)CO, 3D-H(CC)(CO)NH-TOCSY and 3D-(H)CC(CO)NH-TOCSY. All assignment spectra were processed using TopSpin 4.0.2 and analyzed with CARA. Distance restraints for the structure calculation were obtained from 3D 15N NOESY-HSQC (mixing time 150 ms), 3D 13C NOESY-HSQC (mixing time 150 ms) and 2D 13Caro-NOESY-HSQC spectra with automatic peak picking using NMRFAM-SPARKY57. Torsion angle restraints were derived from chemical shift assignments using the TALOS-N web server58. Additional restraints were manually added for Zn2+ coordination, where the Zn2+ ion was included using a CYSZ residue. A structure bundle was calculated using the automated NOE assignment protocol implemented in CYANA, where seven iterations were performed with 100 initial and 20 final structures59. NMR assignments are deposited in the Biological Magnetic Resonance Data Bank (BMRB) under accession number 50997, and the NMR structure is deposited in the PDB under accession number 7PVM.
Titration of substrates
HMQC spectra of 50 μM Xrn2 with different substrates were recorded at 313 K in the presence of 5 mM MgCl2 unless indicated otherwise. 3′,5′-bisphosphoadenosine (100 mM stock solution) was added to a final concentration of 500 μM. 5′-phosphorylated A5-DNA (2 mM stock solution) was added to a final concentration of 200 μM. xrRNA prepared by IVT was added to a final concentration of 100 μM.
Fluorescence anisotropy
Fluorescence anisotropy experiments were performed in 25 mM HEPES (pH 7.3), 125 mM NaCl and 0.002% Triton with fluorescein-labeled 5-mer 5′-GGAGUFsc-3′ and 10-mer 5′-GGAGGAGAGUFsc-3′ RNAs (where UFsc is a thiouridin covalently labeled with iodacetamido-fluorescein) generated as described above. RNA concentrations were 5 nM (5-mer RNA) or 1 nM (10-mer RNA); protein concentrations were 0, 5, 10, 30, 100, 400 and 1,000 nM (5-mer RNA) and 0, 2, 5, 10, 30, 80 and 200 nM (10-mer RNA). Data were acquired with a TECAN Spark microplate reader with excitation and emission wavelengths of 485 nm and 535 nm, respectively. Fluorescence anisotropy data were analyzed with in-house-written MATLAB scripts and fitted to a one-site binding model according to
where robs is the observed anisotropy, rmin is the minimum anisotropy, s is a scaling factor, [RNA] is the concentration of fluorescein-labeled RNA, [P] is the protein concentration and KD is the dissociation constant. The binding experiments were recorded in triplicate; the error (standard deviation) is based on the three measurements. The source data can be found online.
Data processing, analysis and fitting
Methyl-TROSY CPMG pseudo-3D data were processed with NMRPipe56 and analyzed with in-house-written MATLAB scripts. In brief, peak intensities Iυ corresponding to CPMG frequencies υCPMG were extracted from 2D planes with NMRPipe and normalized to a reference intensity I0 obtained by omitting the CPMG element. The normalized intensity Iυ/I0 was then converted into effective transverse relaxation rates R2,eff by assuming an exponential decay. The data were fitted numerically to a global two-state model to extract the exchange parameters pGS, kex, ΔωCi and ΔωHi, R2,Mqi and R2,SQi where the index i refers to the residue number. A minimum standard deviation of 0.2 Hz was assumed for the fit.
19F CPMG pseudo-2D datasets were processed with NMRPipe56 and analyzed with in-house-written MATLAB scripts as described previously38. Minimum standard deviations were set to 2 Hz to avoid excessive weighting of data points with accidentally low errors.
On-resonance R1ρ pseudo-3D datasets were processed with NMRPipe, and R1ρ rates were extracted from the exponential fit of resonance intensities from different spin-lock times TSL. R1ρ data were fitted numerically. To avoid errors arising from approximations, the shift of the average peak was calculated as the imaginary part of the complex eigenvalues of the exchange matrix during parameter optimization. Minimum standard deviations were set to 2 Hz to avoid excessive weighting of data points with accidentally low errors.
To extract errors in the parameters extracted from the NMR relaxation data, 500 cycles of Monte Carlo simulations were carried out by random variation of R2 rates according to their standard deviation and subsequent execution of the numerical fitting routine. Reduced χ2 (χ2υ) surfaces were calculated by constrained fits, in which the probed parameter (kex, pGS or | Δω |) was systematically fixed for a range of values while all other parameters were varied to minimize the value of χ2υ.
The helical wheel in Fig. 3 was generated with DrawCoil 1.0 (https://grigoryanlab.org/drawcoil/). All pictures of structures were prepared with ChimeraX60, and all pictures of 2D NMR spectra were prepared using NMRView (www.onemoonscientific.com). The sequence alignment in Supplementary Fig. 8 was generated with ClustalX 2.1.
Reporting summary
Further information on research design is available in the Nature Research Reporting Summary linked to this article.
Online content
Any methods, additional references, Nature Research reporting summaries, source data, extended data, supplementary information, acknowledgements, peer review information; details of author contributions and competing interests; and statements of data and code availability are available at 10.1038/s41589-022-01111-6.
Supplementary information
Acknowledgements
We thank J. Stöfl for technical assistance in the wet lab and D. Lazzaretti and J. Liebau for constructive comments on the manuscript. We are thankful to all laboratory members for continuous stimulating discussions. This work has been supported by Regensburg University and by the Deutsche Forschungsgemeinschaft (grant SP1324/5-1) to R.S.
Extended data
Source data
Author contributions
J.H.O and R.S. designed experiments. J.H.O. performed experiments and analyzed and interpreted data. D.S. measured turnover rates. A.-L.F. helped with solving the crystal structure of Xrn2. J.P.W. helped with recording and analyzing NMR data of the ZnF and with the NMR structure calculations. J.H.O. and R.S. wrote the manuscript.
Peer review
Peer review information
Nature Chemical Biology thanks the anonymous reviewers for their contribution to the peer review of this work.
Data availability
The structure factors and coordinates for the Xrn2 core protein have been deposited in the PDB under accession code 7OPK. The assignments for the Xrn2 ZnF have been deposited in the BMRB under accession number 50997. The atomic coordinates for the Xrn2 ZnF have been deposited in the PDB under accession code 7PVM. All other relevant data are available in the Source Data provided with this paper and are also available upon reasonable request to the corresponding author.
Competing interests
The authors declare no competing interests.
Footnotes
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Extended data
is available for this paper at 10.1038/s41589-022-01111-6.
Supplementary information
The online version contains supplementary material available at 10.1038/s41589-022-01111-6.
References
- 1.Haimovich G, Choder M, Singer RH, Trcek T. The fate of the messenger is pre-determined: a new model for regulation of gene expression. Biochim. Biophys. Acta. 2013;1829:643–653. doi: 10.1016/j.bbagrm.2013.01.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Rabani M, et al. High-resolution sequencing and modeling identifies distinct dynamic RNA regulatory strategies. Cell. 2014;159:1698–1710. doi: 10.1016/j.cell.2014.11.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Shalem, O. et al. Transient transcriptional responses to stress are generated by opposing effects of mRNA production and degradation. Mol. Syst. Biol.4, 223 (2008). [DOI] [PMC free article] [PubMed]
- 4.Mugridge JS, Coller J, Gross JD. Structural and molecular mechanisms for the control of eukaryotic 5′–3′ mRNA decay. Nat. Struct. Mol. Biol. 2018;25:1077–1085. doi: 10.1038/s41594-018-0164-z. [DOI] [PubMed] [Google Scholar]
- 5.Davidson L, Kerr A, West S. Co-transcriptional degradation of aberrant pre-mRNA by Xrn2. EMBO J. 2012;31:2566–2578. doi: 10.1038/emboj.2012.101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Henry Y, et al. The 5′ end of yeast 5.8S rRNA is generated by exonucleases from an upstream cleavage site. EMBO J. 1994;13:2452–2463. doi: 10.1002/j.1460-2075.1994.tb06530.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Geerlings TH, Vos JC, Raue HA. The final step in the formation of 25S rRNA in Saccharomyces cerevisiae is performed by 5′→3′ exonucleases. RNA. 2000;6:1698–1703. doi: 10.1017/S1355838200001540. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Wang M, Pestov DG. 5′-end surveillance by Xrn2 acts as a shared mechanism for mammalian pre-rRNA maturation and decay. Nucleic Acids Res. 2011;39:1811–1822. doi: 10.1093/nar/gkq1050. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Gasse L, Flemming D, Hurt E. Coordinated ribosomal ITS2 RNA processing by the Las1 complex integrating endonuclease, polynucleotide kinase, and exonuclease activities. Mol. Cell. 2015;60:808–815. doi: 10.1016/j.molcel.2015.10.021. [DOI] [PubMed] [Google Scholar]
- 10.Qu L-H, et al. Seven novel methylation guide small nucleolar RNAs are processed from a common polycistronic transcript by Rat1p and RNase III in yeast. Mol. Cell. Biol. 1999;19:1144–1158. doi: 10.1128/MCB.19.2.1144. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Lee CY, Lee A, Chanfreau G. The roles of endonucleolytic cleavage and exonucleolytic digestion in the 5′-end processing of S. cerevisiae box C/D snoRNAs. RNA. 2003;9:1362–1370. doi: 10.1261/rna.5126203. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.West S, Gromak N, Proudfoot NJ. Human 5′→3′ exonuclease Xm2 promotes transcription termination at co-transcriptional cleavage sites. Nature. 2004;432:522–525. doi: 10.1038/nature03035. [DOI] [PubMed] [Google Scholar]
- 13.Kim M, et al. The yeast Rat1 exonuclease promotes transcription termination by RNA polymerase II. Nature. 2004;432:517–522. doi: 10.1038/nature03041. [DOI] [PubMed] [Google Scholar]
- 14.Luke B, et al. The Rat1p 5′ to 3′ exonuclease degrades telomeric repeat-containing RNA and promotes telomere elongation in Saccharomyces cerevisiae. Mol. Cell. 2008;32:465–477. doi: 10.1016/j.molcel.2008.10.019. [DOI] [PubMed] [Google Scholar]
- 15.Chatterjee S, Großhans H. Active turnover modulates mature microRNA activity in Caenorhabditis elegans. Nature. 2009;461:546–549. doi: 10.1038/nature08349. [DOI] [PubMed] [Google Scholar]
- 16.Chernyakov I, Whipple JM, Kotelawala L, Grayhack EJ, Phizicky EM. Degradation of several hypomodified mature tRNA species in Saccharomyces cerevisiae is mediated by Met22 and the 5′–3′ exonucleases Rat1 and Xrn1. Genes Dev. 2008;22:1369–1380. doi: 10.1101/gad.1654308. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Amberg DC, Goldstein AL, Cole CN. Isolation and characterization of RAT1: an essential gene of Saccharomyces cerevisiae required for the efficient nucleocytoplasmic trafficking of mRNA. Genes Dev. 1992;6:1173–1189. doi: 10.1101/gad.6.7.1173. [DOI] [PubMed] [Google Scholar]
- 18.Kenna M, Stevens A, McCammon M, Douglas MG. An essential yeast gene with homology to the exonuclease-encoding XRN1/KEM1 gene also encodes a protein with exoribonuclease activity. Mol. Cell. Biol. 1993;13:341–350. doi: 10.1128/mcb.13.1.341. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Shobuike T, Tatebayashi K, Tani T, Sugano S, Ikeda H. The dhp1+ gene, encoding a putative nuclear 5′→3′ exoribonuclease, is required for proper chromosome segregation in fission yeast. Nucleic Acids Res. 2001;29:1326–1333. doi: 10.1093/nar/29.6.1326. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Sugano S, Shobuike T, Takeda T, Sugino A, Ikeda H. Molecular analysis of the dhp1+ gene of Schizosaccharomyces pombe: an essential gene that has homology to the DST 2 and RAT 1 genes of Saccharomyces cerevisiae. MGG Mol. Gen. Genet. 1994;243:1–8. doi: 10.1007/BF00283869. [DOI] [PubMed] [Google Scholar]
- 21.Miki TS, Rüegger S, Gaidatzis D, Stadler MB, Großhans H. Engineering of a conditional allele reveals multiple roles of XRN2 in Caenorhabditis elegans development and substrate specificity in microRNA turnover. Nucleic Acids Res. 2014;42:4056–4067. doi: 10.1093/nar/gkt1418. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Stevens A, Poole TL. 5′-exonuclease-2 of Saccharomyces cerevisiae. Purification and features of ribonuclease activity with comparison to 5′-exonuclease-1. J. Biol. Chem. 1995;270:16063–16069. doi: 10.1074/jbc.270.27.16063. [DOI] [PubMed] [Google Scholar]
- 23.Langeberg CJ, et al. Biochemical characterization of yeast Xrn1. Biochemistry. 2020;59:1493–1507. doi: 10.1021/acs.biochem.9b01035. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Stevens A. Purification and characterization of a Saccharomyces cerevisiae exoribonuclease which yields 5′-mononucleotides by a 5′→3′ mode of hydrolysis. J. Biol. Chem. 1980;255:3080–3085. doi: 10.1016/S0021-9258(19)85855-6. [DOI] [PubMed] [Google Scholar]
- 25.Xiang S, et al. Structure and function of the 5′→3′ exoribonuclease Rat1 and its activating partner Rai1. Nature. 2009;458:784–788. doi: 10.1038/nature07731. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Chang JH, Xiang S, Xiang K, Manley JL, Tong L. Structural and biochemical studies of the 5′→3′ exoribonuclease Xrn1. Nat. Struct. Mol. Biol. 2011;18:270–276. doi: 10.1038/nsmb.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Jinek M, Coyle SM, Doudna JA. Coupled 5′ nucleotide recognition and processivity in Xrn1-mediated mRNA decay. Mol. Cell. 2011;41:600–608. doi: 10.1016/j.molcel.2011.02.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Hoek TA, et al. Single-molecule imaging uncovers rules governing nonsense-mediated mRNA decay. Mol. Cell. 2019;75:324–339. doi: 10.1016/j.molcel.2019.05.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Pelechano V, Wei W, Steinmetz LM. Widespread co-translational RNA decay reveals ribosome dynamics. Cell. 2015;161:1400–1412. doi: 10.1016/j.cell.2015.05.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Tesina P, et al. Structure of the 80S ribosome–Xrn1 nuclease complex. Nat. Struct. Mol. Biol. 2019;26:275–280. doi: 10.1038/s41594-019-0202-5. [DOI] [PubMed] [Google Scholar]
- 31.Antic S, Wolfinger MT, Skucha A, Hosiner S, Dorner S. General and microRNA-mediated mRNA degradation occurs on ribosome complexes in Drosophila cells. Mol. Cell. Biol. 2015;35:2309–2320. doi: 10.1128/MCB.01346-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Hu W, Sweet TJ, Chamnongpol S, Baker KE, Coller J. Co-translational mRNA decay in Saccharomyces cerevisiae. Nature. 2009;461:225–229. doi: 10.1038/nature08265. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Eaton JD, West S. Termination of transcription by RNA polymerase II: BOOM! Trends Genet. 2020;36:664–675. doi: 10.1016/j.tig.2020.05.008. [DOI] [PubMed] [Google Scholar]
- 34.Te Chang C, et al. A low-complexity region in human XRN1 directly recruits deadenylation and decapping factors in 5′–3′ messenger RNA decay. Nucleic Acids Res. 2019;47:9282–9295. doi: 10.1093/nar/gkz633. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Page AM, Davis K, Molineux C, Kolodner RD, Johnson AW. Mutational analysis of exoribonuclease I from Saccharomyces cerevisiae. Nucleic Acids Res. 1998;26:3707–3716. doi: 10.1093/nar/26.16.3707. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Solinger JA, Pascolini D, Heyer W-D. Active-site mutations in the Xrn1p exoribonuclease of Saccharomyces cerevisiae reveal a specific role in meiosis. Mol. Cell. Biol. 1999;19:5930–5942. doi: 10.1128/MCB.19.9.5930. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Richter H, Katic I, Gut H, Großhans H. Structural basis and function of XRN2 binding by XTB domains. Nat. Struct. Mol. Biol. 2016;23:164–171. doi: 10.1038/nsmb.3155. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Overbeck JH, Kremer W, Sprangers R. A suite of 19F based relaxation dispersion experiments to assess biomolecular motions. J. Biomol. NMR. 2020;74:753–766. doi: 10.1007/s10858-020-00348-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Akiyama BM, et al. Zika virus produces noncoding RNAs using a multi-pseudoknot structure that confounds a cellular exonuclease. Science. 2016;354:1148–1152. doi: 10.1126/science.aah3963. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Dichtl B, Stevens A, Tollervey D. Lithium toxicity in yeast is due to the inhibition of RNA processing enzymes. EMBO J. 1997;16:7184–7195. doi: 10.1093/emboj/16.23.7184. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Miki TS, Richter H, Rüegger S, Großhans H. PAXT-1 promotes XRN2 activity by stabilizing it through a conserved domain. Mol. Cell. 2014;53:351–360. doi: 10.1016/j.molcel.2014.01.001. [DOI] [PubMed] [Google Scholar]
- 42.Wurm JP, Holdermann I, Overbeck JH, Mayer PHO, Sprangers R. Changes in conformational equilibria regulate the activity of the Dcp2 decapping enzyme. Proc. Natl Acad. Sci. USA. 2017;114:6034–6039. doi: 10.1073/pnas.1704496114. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Popovych N, Sun S, Ebright RH, Kalodimos CG. Dynamically driven protein allostery. Nat. Struct. Mol. Biol. 2006;13:831–838. doi: 10.1038/nsmb1132. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Wurm JP, et al. Molecular basis for the allosteric activation mechanism of the heterodimeric imidazole glycerol phosphate synthase complex. Nat. Commun. 2021;12:2748. doi: 10.1038/s41467-021-22968-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Boehr DD, McElheny D, Dyson HJ, Wrightt PE. The dynamic energy landscape of dihydrofolate reductase catalysis. Science. 2006;313:1638–1642. doi: 10.1126/science.1130258. [DOI] [PubMed] [Google Scholar]
- 46.Neu A, Neu U, Fuchs AL, Schlager B, Sprangers R. An excess of catalytically required motions inhibits the scavenger decapping enzyme. Nat. Chem. Biol. 2015;11:697–704. doi: 10.1038/nchembio.1866. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Fuchs AL, Wurm JP, Neu A, Sprangers R. Molecular basis of the selective processing of short mRNA substrates by the DcpS mRNA decapping enzyme. Proc. Natl Acad. Sci. USA. 2020;117:19237–19244. doi: 10.1073/pnas.2009362117. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.S. Schütz, R. Sprangers, Methyl TROSY spectroscopy: a versatile NMR approach to study challenging biological systems. Prog. Nucl. Magn. Reson. Spectrosc.116, 56–84 (2019). [DOI] [PubMed]
- 49.Boehr DD, Dyson HJ, Wright PE. Conformational relaxation following hydride transfer plays a limiting role in dihydrofolate reductase catalysis. Biochemistry. 2008;47:9227–9233. doi: 10.1021/bi801102e. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Wolf-Watz M, et al. Linkage between dynamics and catalysis in a thermophilic-mesophilic enzyme pair. Nat. Struct. Mol. Biol. 2004;11:945–949. doi: 10.1038/nsmb821. [DOI] [PubMed] [Google Scholar]
- 51.Kabsch W. XDS. Acta Crystallogr. D Biol. Crystallogr. 2010;66:125–132. doi: 10.1107/S0907444909047337. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.McCoy AJ, et al. Phaser crystallographic software. J. Appl. Crystallogr. 2007;40:658–674. doi: 10.1107/S0021889807021206. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Emsley P, Lohkamp B, Scott WG, Cowtan K. Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 2010;66:486–501. doi: 10.1107/S0907444910007493. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Liebschner D, et al. Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix. Acta Crystallogr. D Struct. Biol. 2019;75:861–877. doi: 10.1107/S2059798319011471. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Korzhnev DM, Kloiber K, Kanelis V, Tugarinov V, Kay LE. Probing slow dynamics in high molecular weight proteins by methyl-TROSY NMR spectroscopy: application to a 723-residue enzyme. J. Am. Chem. Soc. 2004;126:3964–3973. doi: 10.1021/ja039587i. [DOI] [PubMed] [Google Scholar]
- 56.Delaglio F, et al. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR. 1995;6:277–293. doi: 10.1007/BF00197809. [DOI] [PubMed] [Google Scholar]
- 57.Lee W, Tonelli M, Markley JL. NMRFAM-SPARKY: enhanced software for biomolecular NMR spectroscopy. Bioinformatics. 2015;31:1325–1327. doi: 10.1093/bioinformatics/btu830. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Shen Y, Bax A. Protein backbone and sidechain torsion angles predicted from NMR chemical shifts using artificial neural networks. J. Biomol. NMR. 2013;56:227–241. doi: 10.1007/s10858-013-9741-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Güntert P, Buchner L. Combined automated NOE assignment and structure calculation with CYANA. J. Biomol. NMR. 2015;62:453–471. doi: 10.1007/s10858-015-9924-9. [DOI] [PubMed] [Google Scholar]
- 60.Pettersen EF, et al. UCSF ChimeraX: structure visualization for researchers, educators, and developers. Protein Sci. 2021;30:70–82. doi: 10.1002/pro.3943. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The structure factors and coordinates for the Xrn2 core protein have been deposited in the PDB under accession code 7OPK. The assignments for the Xrn2 ZnF have been deposited in the BMRB under accession number 50997. The atomic coordinates for the Xrn2 ZnF have been deposited in the PDB under accession code 7PVM. All other relevant data are available in the Source Data provided with this paper and are also available upon reasonable request to the corresponding author.